iCAD, Inc. (ICAD) - Sof foyda bo'yicha sotuv rentabelligi

icadmed.com (ICAD) korporativ emblemasi va logotipi

Sof foyda marjasi AI platformalari orqali mammogramma tahlilining avtomatlashtirish dinamikasini aks ettiradi. Patologiyani erta aniqlashda kompyuter ko'rishining yuqori aniqligi va ProFound dasturiy ta'minotining onkologiya markazlariga B2B integratsiyasi biznes barqarorligini ta'minlaydi. Shu bilan birga, -26.80 darajasi eng so'nggi savdo marjasi ko'rsatkichlarini qamrab oladi, bu esa iCAD, Inc. (ICAD) samaradorligini sanoat rentabellik standartlariga nisbatan real vaqt rejimida baholash imkonini beradi.

iCAD (ICAD) - Kompaniya sotuv marjasi 04.07.2022dan 02.08.2025gacha

iCAD Inc. (ICAD) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning barcha koʻrsatkichlari tahlili:iCAD - ICAD
iCAD yetakchi tovari

Investorlar iCAD, Inc. (ICAD) kompaniyasining bozor tebranishlariga qarshi bardoshliligiga jalb qilinmoqda. Sof marja barcha xarajatlar tushumdan chegirib tashlanganidan keyin qolgan foyda qismini o'lchaydi va savdoni kapitalga aylantirish samaradorligini belgilaydi. Foyda marjasi koeffitsiyentini tahlil qilish orqali biznesning pul oqimini yaratish qobiliyatini baholash mumkin. AI yordamida ko'krak saratoni diagnostikasi segmentidagi kuchli narx belgilash imkoniyati ushbu ko'rsatkichni qo'llab-quvvatlaydi. Ushbu ko'rsatkichning fundamental o'sishi ProFound AI platformasining noyobligini tasdiqlaydi.

iCAD, Inc. (ICAD) raqobatchilari

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|CRIS - Sof foyda bo'yicha sotuv rentabelligi|Apollomics - Sotuvning sof marjinal rentabelligi|Tharimmune Corp (THAR) - Sof foyda bo'yicha sotuv rentabelligi|ADVB: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi SBFM (Sunshine Biopharma)|Sof marja Xenetic Bio (XBIO)|Sof marja SLRX (Salarius Pharma)|Kitov Pharma - Sof foyda bo'yicha sotuv rentabelligi|American Oncology Network (AONC) - Sof marja|BeiGene - Sotuvning sof marjinal rentabelligi|Checkpoint Therapeutics, Inc. (CKPT) - Sof foyda bo'yicha sotuv rentabelligi|ELEV (Elevation Oncology, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)